In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Pereira, Bernardo A S ^a,b   Silva, Franklin S ^a   Rebello, Karina M ^a   Marín Villa, Marcel ^a   Traub Cseko, Yara M ^a   Andrade, Thereza C B ^a   Bertho, Álvaro L ^a   Caffarena, Ernesto R ^a   Alves, Carlos R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Presidência ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE B; UNCLASSIFIED DRUG; CYTOKINE; EPITOPE; H2 ANTIGEN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPUTER MODEL; FEMALE; IMMUNE RESPONSE; INFECTION SENSITIVITY; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CBA MOUSE; GENETICS; IMMUNOLOGY; LEISHMANIA MEXICANA; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PARASITOLOGY; PATHOGENICITY; PROTEIN BINDING; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CYSTEINE PROTEASES; CYTOKINES; EPITOPES; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; LEISHMANIA MEXICANA; LEISHMANIASIS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 79961120705     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-44     Document Type: Article

References (33)

1. Herwaldt BL. Leishmaniasis. Lancet 1999, 354:1191-1199. 10.1016/S0140-6736(98)10178-2, 10513726.
2. Awasthi A, Kumar R, Saha B. Immune response to Leishmania infection. Indian J Med Res 2004, 119:238-258.
3. Oliveira CC, Lacerda HG, Martins DR, Barbosa JD, Monteiro GR, Queiroz JW, Sousa JM, Ximenes MF, Jeronimo SM. Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface. Acta Trop 2004, 90:155-162. 10.1016/j.actatropica.2003.11.011, 15177141.
4. Barral A, Pedral-Sampaio D, Grimaldi Júnior G, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badaró R, Barral-Netto M, Carvalho EM, Johnson WD. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991, 44:536-546.
5. Azeredo-Coutinho RB, Conceição-Silva F, Schubach A, Cupolillo E, Quintella LP, Madeira MF, Pacheco RS, Valete-Rosalino CM, Mendonça SC. First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil. Trans R Soc Trop Med Hyg 2007, 101:735-737. 10.1016/j.trstmh.2007.01.005, 17368698.
6. Pereira BAS, Alves CR. Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis. Vet Parasitol 2008, 158:239-255. 10.1016/j.vetpar.2008.09.015, 18922635.
7. Alexander J, Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 2005, 99:17-23. 10.1016/j.imlet.2005.01.009, 15894106.
8. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol Rev 2004, 201:206-224. 10.1111/j.0105-2896.2004.00190.x, 15361243.
9. Anderson CF, Mendez S, Sacks DL. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J Immunol 2005, 174:2934-2941.
10. Mottram JC, Coombs GH, Alexander J. Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol 2004, 7:375-381. 10.1016/j.mib.2004.06.010, 15358255.
11. Mottram JC, Brooks DR, Coombs GH. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr Opin Microbiol 1998, 1:455-460. 10.1016/S1369-5274(98)80065-9, 10066510.
12. De Souza Leao S, Lang T, Prina E, Hellio R, Antoine JC. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J Cell Sci 1995, 108:3219-3231.
13. Pollock KG, McNeil KS, Mottram JC, Lyons RE, Brewer JM, Scott P, Coombs GH, Alexander J. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J Immunol 2003, 170:1746-1753.
14. Weinheber N, Wolfram M, Harbecke D, Aebischer T. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur J Immunol 1998, 28:2467-2477. 10.1002/(SICI)1521-4141(199808)28:08<2467::AID-IMMU2467>3.0.CO;2-1, 9710224.
15. Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol 2004, 173:3297-3304.
16. Duboise SM, Vannier-Santos MA, Costa-Pinto D, Rivas L, Pan AA, Traub-Cseko Y, De Souza W, McMahon-Pratt D. The biosynthesis, processing, and immunolocalization of Leishmania pifanoi amastigote cysteine proteinases. Mol Biochem Parasitol 1994, 68:119-132. 10.1016/0166-6851(94)00157-X, 7891736.
17. Traub-Cseko YM, Duboise M, Boukai LK, McMahon-Pratt D. Identification of two distinct cysteine proteinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction. Mol Biochem Parasitol 1993, 57:101-115. 10.1016/0166-6851(93)90248-V, 8426606.
18. Alves CR, Corte-Real S, Bourguignon SC, Chaves CS, Saraiva EM. Leishmania amazonensis: early proteinase activities during promastigote-amastigote differentiation in vitro. Exp Parasitol 2005, 109:38-48. 10.1016/j.exppara.2004.10.005, 15639138.
19. Marin-Villa M, Vargas-Inchaustegui DA, Chaves SP, Tempone AJ, Dutra JM, Soares MJ, Ueda-Nakamura T, Mendonça SC, Rossi-Bergmann B, Soong L, Traub-Cseko YM. The C-terminal extension of Leishmania pifanoi amastigote-specific cysteine proteinase Lpcys2: a putative function in macrophage infection. Mol Biochem Parasitol 2008, 162:52-59. 10.1016/j.molbiopara.2008.07.003, 18694784.
20. Alves CR, Pontes de Carvalho LC, Souza AL, De Simone SG. A strategy for the identification of T-cell epitopes on Leishmania cysteine proteinases. Cytobios 2001, 104:33-41.
21. Alves CR, Benevolo-De-Andrade TC, Alves JL, Pirmez C. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis. Parasite Immunol 2004, 26:127-135. 10.1111/j.0141-9838.2004.00691.x, 15279623.
22. Soong L, Chang CH, Sun J, Longley BJ, Ruddle NH, Flavell RA, McMahon-Pratt D. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol 1997, 158:5374-5383.
23. Guerfali FZ, Ben-Abdallah H, Sghaier RM, Ben-Aissa K, Mkannez G, Attia H, Laouini D. An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection. Infect Genet Evol 2009, 9:344-350. 10.1016/j.meegid.2008.02.011, 18420466.
24. Ji J, Sun J, Qi H, Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg 2002, 66:338-345.
25. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002, 2:845-858. 10.1038/nri933, 12415308.
26. Carter LL, Dutton RW. Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996, 8:336-342. 10.1016/S0952-7915(96)80122-1, 8793995.
27. Carvalho EM, Baaró R, Reed SG, Jones TC, Johnson WD. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 1985, 76:2066-2069. 10.1172/JCI112209, 424308, 3935667.
28. Barral-Netto M, Roters SB, Barral A. Interleukin- 2 production during murine infection by Leishmania mexicana amazonensis. Mem Inst Oswaldo Cruz 1986, 81:43-47.
29. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126:131-138. 10.1016/0003-2697(82)90118-X, 7181105.
30. Scott WRP, Huenenberger PH, Tironi IG, Mark AE, Billeter SR, Fennen J, Torda AE, Huber T, Krueger P, van Gunsteren WF. The GROMOS Biomolecular Simulation Program Package. J Phys Chem A 1999, 103:3596-3607.
31. Harding CV. Pathways of antigen processing. Curr Opin Immunol 1991, 3:3-9. 10.1016/0952-7915(91)90068-C, 2054112.
32. Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit 1996, 9:1-5. 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6, 8723313.
33. Ogata K, Wodak SJ. Conserved water molecules in MHC class-I molecules and their putative structural and functional roles. Protein Engineering 2002, 15:697-705. 10.1093/protein/15.8.697, 12364585.